Policy consultations
You are here:

ACN’s Policy team seeks opportunities to promote nursing and advocate for optimal community health outcomes by responding to consultations and inquiries conducted by Australian Government departments, federal and state parliaments and other organisations.

Click on the + symbol below to find out more about the listed consultations and how you can have your say.

ACN consultations

The Pharmaceutical Benefits Advisory Committee (PBAC) of the Department of Health is carrying out a consultation on the Final Terms of Reference of the post-market review of medicines for smoking cessation (Final Terms of Reference).

The final Terms of Reference for the Review are as follows:

  • Collate the current clinical guidelines for medicines for smoking cessation and compare these to the Therapeutic Goods Administration (TGA) and Pharmaceutical Benefits Scheme (PBS) restrictions for these medicines.
  • Review the utilisation of PBS-listed medicines for smoking cessation including but not limited to patient demographics, time on treatment, and the proportion using PBS subsidised combination treatment.
  • Review the efficacy and safety of nicotine replacement therapy, varenicline and bupropion for smoking cessation including combination therapies not currently PBS subsidised.
  • Subject to the findings of Terms of Reference 1, 2 and 3, review the cost-effectiveness of medicines for smoking cessation.

This is an opportunity for stakeholders to identify issues that might relate to the post-market review of smoking cessation medicines and provide any evidence or data, particularly evidence that the PBAC may not have previously considered.

The Australian College of Nursing (ACN) would like to invite you to provide feedback on this consultation. Please provide your comment to contribute to ACN’s response using this survey by Friday 17 April 2020.

Direct response consultations

The Department of Veterans’ Affairs (DVA) has engaged Nous Group (Nous) to conduct a survey to obtain feedback on your experiences of the following:

  • Repatriation Pharmaceutical Benefits Scheme (RPBS) Authority Phone Line
  • The Dose Administration Aid program (DAA)
  • The RPBS and the Repatriation Pharmaceutical Reference Committee (RPRC).

The survey closes on Sunday 31 May 2020.

The survey is applicable to a wide range of nurses in particular nurse practitioners, advanced practice nurses, nurses in general practice and nurses working in the area of wound care. Further details and the link to the survey are available at the Nous website.

For questions and points of clarification directly related to the survey, please contact this email address: NousReviewRPBS@nousgroup.com.au

Thank you for taking the time to complete the survey if applicable to your practice and area of expertise. It will be important in making sure the nursing perspective is included in the survey results.